About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Organizations Butler
Research Type Clinical
Therapeutic Area of Study Parkinson's Disease/Movement Disorders
Principal Investigators
Eligibility Criteria Male or female 30 years or older with early Parkinson’s disease who are not yet on treatment for Parkinson’s
Recruitment Status Open
Date Study Started 07/01/2007
Date Study Ends 07/01/2014
Contact Information

For more information contact Lisa at 401-455-6667.

Description

This study is using oral inosine to try to slow the progression of Parkinson’s disease in those with early PD. Inosine raises serum uric acid, which, by strong epidemiological evidence, is associated with reduced incidence of PD and slow progression. This study lasts approximately 2 years with 16 visits over that time period. This study is sponsored by the Michael J. Fox Foundation

Look for another study
Health Headlines
CDC Confirms First Patient Diagnosed With Ebola in United StatesView in a lightbox
A Little Booze Does Get Men Smiling, Study ConfirmsView in a lightbox
Experimental Cervical Cancer Vaccine Looks Promising in TrialView in a lightbox
Gene Study Finds No Proof Vitamin D Guards Against Type 2 DiabetesView in a lightbox
Health Highlights: Oct. 1, 2014View in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health